Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ligand Pharmaceuticals Stock (NASDAQ: LGND) stock price, news, charts, stock research, profile.
Open | $103.29 |
Close | - |
Volume / Avg. | 62.15K / 125.80K |
Day Range | $99.27 - $103.29 |
52 Wk Range | 49.24 - 112.13 |
Market Cap | $1.81B |
P/E Ratio | 44.20 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 7.63% |
Days to Cover | 9.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ligand Pharmaceuticals (NASDAQ:LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Neumora Therapeutics (NASDAQ:NMRA).
Ligand Pharmaceuticals has a consensus price target of $122.00.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $99.27 last updated September 23, 2024 at 2:29 PM EDT.
A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 19, 2007 to stockholders of record on April 3, 2007.
Ligand Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.